Ex parte SACRIPANTE et al. - Page 4




               Appeal No. 1996-1371                                                                                                
               Application 08/221,595                                                                                              


               acknowledges that Sacripante does not disclose such a three component toner                                         
               composition.  We are aware of the disclosure at column 6, lines 10-16 which would appear                            
               to describe a three component toner composition.  However, this described toner                                     
               composition requires a charge control additive in addition to the sulfonated polyester                              
               polymer which serves as the charge control additive in the claimed composition.  Further,                           
               this description fails to define the charge enhancing agent in a manner which would                                 
               reasonably be read to encompass the polymer required by the claim.  A claim is                                      
               anticipated only if each and every element as set forth in the claim is found, either                               
               expressly or inherently described, in a single prior art reference.  Verdegaal Bros., Inc. v.                       
               Union Oil Co., 814 F.2d 628, 631, 2 USPQ2d 1051, 1053 (Fed. Cir.), cert. denied, 484                                
               U.S. 827 (1987).  Here, the reference does not disclose a three component toner                                     
               composition wherein the charge enhancing polyester has a chemically attached moiety                                 
               selected from the claim designated group of sulfoisophthalates.  Thus, it fails to anticipate                       
               the rejected claims.  Therefore the rejections under 35 U.S.C. § 102 are reversed.                                  
                                            The rejections under 35 U.S.C. § 103                                                   
                       Claims 1, 7, 8, 10, 14-19, 25, and 29 stand rejected under 35 U.S.C. § 103 as                               
               unpatentable over Sacripante alone or in combination with Alexandrovich and Diamond.                                
               Since the rejection of the claims over Sacripante alone is subsumed by the rejection over                           
               the combination of Sacripante, Alexandrovich, and Diamond, we will limit our discussion to                          


                                                                4                                                                  





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007